Coloplast chief wants to unfold full potential with upcoming strategy
Four growth platforms will be the main focus when Coloplast embarks on a new strategy period in a year’s time, says the medical device company’s chief executive.
With about a year to go until the expiration date of Coloplast’s current strategy, CEO Kristian Villumsen is already ready to lay out the broad outlines for the company’s next strategy period, according to an interview with MedWatch in connection with the medical device company’s capital markets day held on Thursday last week.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Coloplast launches catheter version for women
For subscribers
